Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC
businesswire.com
news
2022-10-19 00:00:00

LOS ANGELES--(BUSINESS WIRE)--According to a comprehensive market report authored by DeciBio Consulting LLC, 'Oncology Liquid Biopsy (LBx) Market Report 2022 - 2027,' the global oncology liquid biopsy market, driven by growth in new applications – primarily minimum residual disease (MRD) testing, serial monitoring, and early cancer detection – is predicted to reach $8.6B by 2027.

This second edition of DeciBio's liquid biopsy report takes an updated and comprehensive look at the liquid biopsy (LBx) landscape.
